Publications by date:

Development of System-Level Performance Measures for Evaluation of Models of Care for Inflammatory Arthritis in Canada

March 1, 2016

AUTHORS: Barber, C.E., Marshall, D.A., Mosher, D.P., Akhavan, P., Tucker, L., Houghton, K., Batthish, M., Levy, D.M., Schmeling, H., Ellsworth, J.…

Read More

Recommendations for kidney disease guideline updating: a report by the KDIGO Methods Committee

January 19, 2016

AUTHORS: Uhlig, K., Berns, J.S., Carville, S., Chan, W., Cheung, M., Guyatt, G.H., Hart, A., Lewis, S.Z., Tonelli, M., Webster, A.C.…

Read More

Assessing Janus Kinase Inhibitor’s Place in Therapy in Established Rheumatoid Arthritis Patients-From a Simplified Indirect Comparison Versus Tumor Necrosis Factor Inhibitors to a Bayesian Probability of Response-The Value Of Transparency

October 30, 2013

AUTHORS: Ingham, M.P., Song, P., Cartier, S., Lawson-Remer, K. and Murray, E. Publication: Arthritis and Rheumatism. Vol. 65. 111 River St, Hoboken…

Read More

Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma

December 11, 2011

AUTHORS: Berenson, K.L., Kymes, S., Hollander, D.A., Fiscella, R., Burk, C. and Patel, V.D. Publication: The American journal of managed care 17.9…

Read More

Demonstration of an Online Tool to Assist Care Formulary Evidence-based Decision-making: Meta-analysis of Topical Prostaglandin Analog Efficacy

July 11, 2011

AUTHORS: Kymes, S.M., Burk, C., Feinman, T., Williams, J.M. and Hollander, D.A. Publication: ITherapeutics and Clinical Risk Management, 2011; 7: 283–290. Published…

Read More